Resources
FEATURED CASE STUDY
Coinbase Saves Millions, Reduces Experiment Analysis Time by 40%, and Restores Trust in Experimentation with Eppo
Learn more
Eppo is the next-gen A/B testing platform enabling teams to 10x experiment velocity while maintaining rigor.
Warehouse-native architecture powers a world class statistical engine without becoming a black box. Automate experiment analysis while maintaining rigor.
Fast and resilient feature flags for A/B tests, feature gates, controlled rollouts, kill switches, and dynamic no-code configuration. Simple to get started, and built to scale.
Unlock new possibilities in personalization with Contextual Bandits. Automatically optimize user experiences in real-time, or get more value from your AI models.
Eppo delivers what an experiment-driven culture needs.
Trusted statistical frameworks for analysis—sequential, fixed sample, and Bayesian—all implemented rigorously. Plus we offer the most robust implementation of CUPED variance reduction.
Run experiments from a single source of truth and measure impact on core business metrics. No egressing of sensitive data or shadow warehouse syncs. Optimized to keep data warehouse costs down.
Connect with experimentation veterans to optimize your practice. Eppo gives you not only the tooling, but also access to world-class experimenters and the building blocks to nurture an experimentation culture in your org.
Eppo is designed to make it easy for technical and non-technical teammates alike to self-serve experiment setup, monitoring, and analysis—no special knowledge is required.
Optimize user onboarding experiences, stimulate viral loops, identify areas to reduce friction, and more.
From simple on-off flags to gradual rollouts and full-blown experiments, we make it easy to allocate traffic and test across environments.
Build more effective AI products. Evaluate AI models by running experiments with trusted business metrics.
Better understand how your email campaigns and SMS nudges are helping you increase feature adoption, reduce churn risk, and more.